Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses lung cancer in…
A study presented at the American Association for Cancer Research meeting showed progression of androgen-independent prostate cancer was significantly inhibited in mice by a combination of atorvastatin (Lipitor)…
Rituximab failed to meet the primary endpoint of stemming the progression of primary-progressive multiple sclerosis (PPMS) in a Phase II/III trial. From Our Partners at VerusMed verusmed.com Sponsored…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses treatment therapies and…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses his website OncTalk,…
At the American Academy of Neurology meeting, researchers gave final results of the phase III PRECISE trial of glatiramer acetate (Copaxone), which delayed the onset of clinically confirmed…
Vineet Arora, MD, MA, Assistant Professor of Medicine, Assistant Dean of Curricular Innovation of Pritzker School of Medicine, and Associate Program Director of the Internal Medicine Residency Program,…
Bill Crounse, MD, Senior Director for Worldwide Health, Microsoft Corporation, discusses his transition from a practicing physician to a Senior Director at Microsoft. For the Bill Crounse, MD…
As reported at the American Academy of Ophthalmology meeting, the frequency of ocular MRSA increased by almost 60% in the first six years of the decade. aao.org Sponsored…
The FDA has approved regadenoson (Lexiscan) injection for patients unable to exercise sufficiently for a coronary stress test. fda.gov Sponsored by The Doctor’s Channel
